Please assess the completion status of the following clinical trial:

Trial Title: Vaginal Preparation and Azithromycin to Reduce Post Cesarean Infections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* full term pregnancy~* undergoing labored, non-emergent cesarean section~* patient in labor~Exclusion Criteria:~Azithromycin contraindicated:~* Known hypersensitivity to azithromycin, erythromycin, macrolides or ketolide medications.~* liver dysfunction~* Prescription medications which may interact with azithromycin, such as nelfinavir or warfarin~* A history of a cardiac dysrhythmia (irregular heartbeats)~* Known hypersensitivity to iodine~* Patients carrying fetuses with known congenital anomalies~* Immunodeficiency~* Patients who are not in labor at the time of delivery~* Non-english speaking subjects or subjects with language barriers

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: t

Study Arms:
- Vaginal Preparation (Type: EXPERIMENTAL): In addition to standard care, subjects will undergo vaginal preparation (VP). A VP kit includes sponge sticks and sponges soaked in a povidone-iodine 10% solution.
- Standard Infection Procedures (Type: SHAM_COMPARATOR): The very staff will follow hospital protocols for the cesarean delivery. The subject and the infant will be provided care in accordance with current medical standards and be discharged at the discretion of the attending physician.

Based on this trial design, predict the completion outcome and termination type (if applicable).